Epidiolex, the only plant-derived cannabis drug approved by the U.S. Food and Drug Administration, is no longer considered a controlled substance, providing a boost to its manufacturer’s stock price. GW Pharmaceuticals, a biopharmaceutical company based in London, saw its stock go up 5.9% on Tuesday, one day after the U.S. Drug Enforcement Administration said it […]

DEA removes cannabis drug Epidiolex from controlled substances list is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs